$IOR
INCOME OPPORTUNITY REALTY INVESTORS INC /TX/

2023 Q3 Form 10-Q Financial Statement

#000138713123009556 Filed on August 10, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $440.0K $456.0K $341.0K
YoY Change 10.83% 33.72% -4.21%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $440.0K $456.0K $341.0K
YoY Change 10.83% 33.72% -4.21%
Operating Profit -$437.0K -$456.0K -$341.0K
YoY Change 10.08% 33.72% -4.21%
Interest Expense $2.516M $2.778M $1.433M
YoY Change 38.17% 93.86% 16.41%
% of Operating Profit
Other Income/Expense, Net $0.00
YoY Change -100.0%
Pretax Income $2.080M $2.322M $1.092M
YoY Change 46.07% 112.64% 5.3%
Income Tax $436.0K $488.0K $244.0K
% Of Pretax Income 20.96% 21.02% 22.34%
Net Earnings $1.643M $1.834M $848.0K
YoY Change 38.3% 116.27% 3.54%
Net Earnings / Revenue
Basic Earnings Per Share $0.39 $0.44 $0.20
Diluted Earnings Per Share $0.39 $0.44 $0.20
COMMON SHARES
Basic Shares Outstanding 4.168M shares 4.168M shares 4.168M shares
Diluted Shares Outstanding 4.168M shares 4.168M shares 4.168M shares

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00 $2.000K $1.000K
YoY Change -100.0% 100.0% -50.0%
Cash & Equivalents $12.00K $2.000K $1.000K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $104.8M $103.0M $97.69M
Other Receivables $104.8M $103.0M $0.00
Total Short-Term Assets $105.3M $103.7M $98.36M
YoY Change 5.81% 5.43% 3.75%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $11.17M $11.17M $11.17M
YoY Change 0.0% 0.0% -5.61%
TOTAL ASSETS
Total Short-Term Assets $105.3M $103.7M $98.36M
Total Long-Term Assets $11.17M $11.17M $11.17M
Total Assets $116.5M $114.9M $109.5M
YoY Change 5.23% 4.88% 2.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.000K $1.000K $1.000K
YoY Change -90.91% 0.0% -88.89%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.000K $1.000K
YoY Change 0.0% -88.89%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.000K $1.000K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $0.00 $1.000K $1.000K
YoY Change -100.0% 0.0% -88.89%
SHAREHOLDERS EQUITY
Retained Earnings $54.55M $52.91M $47.57M
YoY Change 11.89% 11.23%
Common Stock $62.00M $62.00M $62.00M
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $39.00K $39.00K $39.00K
YoY Change 0.0% 0.0%
Treasury Stock Shares 5.261K shares
Shareholders Equity $116.5M $114.9M $109.5M
YoY Change
Total Liabilities & Shareholders Equity $116.5M $114.9M $109.5M
YoY Change 5.23% 4.88% 2.71%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income $1.643M $1.834M $848.0K
YoY Change 38.3% 116.27% 3.54%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $10.00K -$4.000K -$4.000K
YoY Change 0.0% 0.0% -100.06%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities 10.00K -4.000K -4.000K
Cash From Investing Activities 0.000
Cash From Financing Activities
Net Change In Cash 10.00K -4.000K -4.000K
YoY Change 0.0% 0.0% -300.0%
FREE CASH FLOW
Cash From Operating Activities $10.00K -$4.000K -$4.000K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0000949961
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-14784
dei Entity Registrant Name
EntityRegistrantName
INCOME OPPORTUNITY REALTY INVESTORS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
75-2615944
dei Entity Address Address Line1
EntityAddressAddressLine1
1603 Lyndon B. Johnson Freeway
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 800
dei Entity Address City Or Town
EntityAddressCityOrTown
Dallas
dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
75234
dei City Area Code
CityAreaCode
(469)
dei Local Phone Number
LocalPhoneNumber
522-4200
dei Security12b Title
Security12bTitle
Common Stock
dei Trading Symbol
TradingSymbol
IOR
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
4168414 shares
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6000 usd
CY2023Q2 us-gaap Interest Receivable
InterestReceivable
665000 usd
CY2022Q4 us-gaap Interest Receivable
InterestReceivable
676000 usd
CY2023Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
103030000 usd
CY2022Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
100134000 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
103697000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
100816000 usd
CY2023Q2 us-gaap Notes Receivable Net
NotesReceivableNet
11173000 usd
CY2022Q4 us-gaap Notes Receivable Net
NotesReceivableNet
11173000 usd
CY2023Q2 us-gaap Assets
Assets
114870000 usd
CY2022Q4 us-gaap Assets
Assets
111989000 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4000 usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4173675 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4173675 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4168414 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4168414 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
42000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
42000 usd
CY2023Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
5261 shares
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
5261 shares
CY2023Q2 us-gaap Treasury Stock Value
TreasuryStockValue
39000 usd
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
39000 usd
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
61955000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
61955000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
52911000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
50027000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
114869000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
111985000 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
114870000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
111989000 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
76000 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
68000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
294000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
260000 usd
CY2023Q2 ior Advisory Fee To Related Party
AdvisoryFeeToRelatedParty
380000 usd
CY2022Q2 ior Advisory Fee To Related Party
AdvisoryFeeToRelatedParty
273000 usd
ior Advisory Fee To Related Party
AdvisoryFeeToRelatedParty
699000 usd
ior Advisory Fee To Related Party
AdvisoryFeeToRelatedParty
541000 usd
CY2023Q2 us-gaap Costs And Expenses
CostsAndExpenses
456000 usd
CY2022Q2 us-gaap Costs And Expenses
CostsAndExpenses
341000 usd
us-gaap Costs And Expenses
CostsAndExpenses
993000 usd
us-gaap Costs And Expenses
CostsAndExpenses
801000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-456000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-341000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-993000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-801000 usd
CY2023Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
2778000 usd
CY2022Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1433000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
4644000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
2685000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
488000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
244000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
767000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
410000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
1834000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
848000 usd
us-gaap Net Income Loss
NetIncomeLoss
2884000 usd
us-gaap Net Income Loss
NetIncomeLoss
1474000 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.44
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.44
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.20
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.20
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.69
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.69
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.35
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.35
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4168414 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4168414 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4168414 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4168414 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4168414 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4168414 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4168414 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4168414 shares
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
113035000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
1834000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
114869000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
108680000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
848000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
109528000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
111985000 usd
us-gaap Net Income Loss
NetIncomeLoss
2884000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
114869000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
108054000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
108054000 usd
us-gaap Net Income Loss
NetIncomeLoss
1474000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
109528000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
109528000 usd
us-gaap Net Income Loss
NetIncomeLoss
2884000 usd
us-gaap Net Income Loss
NetIncomeLoss
1474000 usd
us-gaap Increase Decrease In Notes Receivable Related Parties
IncreaseDecreaseInNotesReceivableRelatedParties
-11000 usd
us-gaap Increase Decrease In Notes Receivable Related Parties
IncreaseDecreaseInNotesReceivableRelatedParties
74000 usd
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
2896000 usd
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
1390000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-11000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1000 usd
CY2023Q2 us-gaap Notes Receivable Net
NotesReceivableNet
11173000 usd
CY2022Q4 us-gaap Notes Receivable Net
NotesReceivableNet
11173000 usd

Files In Submission

Name View Source Status
0001387131-23-009556-index-headers.html Edgar Link pending
0001387131-23-009556-index.html Edgar Link pending
0001387131-23-009556.txt Edgar Link pending
0001387131-23-009556-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
ior-10q_063023.htm Edgar Link pending
ior-20230630.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
ior-20230630_cal.xml Edgar Link unprocessable
ior-20230630_lab.xml Edgar Link unprocessable
ior-20230630_def.xml Edgar Link unprocessable
ior-20230630_pre.xml Edgar Link unprocessable
ior-10q_063023_htm.xml Edgar Link completed